Abbott India Ltd.
| BSE: 500488 | Sector: Health care |
| NSE: ABBOTINDIA | ISIN Code: INE358A01014 |
| BSE 00:00 | 07 May | 15853.10 |
428.80 (2.78%) |
OPEN
15473.80 |
HIGH
15900.00 |
LOW
15316.40 |
| NSE 00:00 | 07 May | 15850.40 |
427.65 (2.77%) |
OPEN
15458.95 |
HIGH
15900.00 |
LOW
15329.50 |
| OPEN | 15473.80 |
| PREVIOUS CLOSE | 15424.30 |
| VOLUME | 2685 |
| 52-Week high | 18450.00 |
| 52-Week low | 13970.10 |
| P/E | 51.89 |
| Mkt Cap.(Rs cr) | 33,688 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Abbott India Ltd. (ABBOTINDIA) - Competition
| COMPANY | Last Price | Market Cap. (Rs. cr.) |
Sales Turnover | Net Profit | Total Assets |
| Sun Pharma.Inds. | 679.50 | 163,032.43 | 12,531.93 | 3,211.14 | 32,355.78 |
| Divi's Lab. | 4,029.50 | 106,963.08 | 5,310.57 | 1,372.71 | 7,370.84 |
| Dr Reddy's Labs | 5,173.55 | 86,036.14 | 11,850.40 | 2,937.70 | 16,732.90 |
| Cipla | 882.95 | 71,205.50 | 12,659.15 | 2,318.17 | 17,704.77 |
| Cadila Health. | 603.10 | 61,739.35 | 6,347.40 | 1,412.90 | 15,089.80 |
| Aurobindo Pharma | 1,012.75 | 59,337.02 | 13,266.48 | 1,872.74 | 16,809.46 |
| Lupin | 1,195.60 | 54,250.35 | 11,025.66 | 727.55 | 17,937.29 |
| Apollo Hospitals | 3,311.85 | 47,617.78 | 9,794.50 | 470.30 | 8,570.00 |
| Biocon | 381.10 | 45,754.87 | 1,988.40 | 440.90 | 7,583.50 |
| Torrent Pharma. | 2,616.15 | 44,270.49 | 6,168.44 | 938.51 | 10,683.66 |
| Gland Pharma | 2,647.50 | 43,392.52 | 2,633.24 | 772.86 | 3,653.86 |
| Piramal Enterp. | 1,670.45 | 37,677.00 | 4,219.19 | 144.85 | 33,415.39 |
| Alkem Lab | 2,908.20 | 34,767.53 | 6,677.08 | 1,264.42 | 7,728.19 |
| Abbott India | 15,853.10 | 33,687.84 | 4,093.14 | 592.93 | 2,691.43 |
| Laurus Labs | 487.45 | 26,156.57 | 2,797.34 | 267.05 | 2,966.39 |
| Ipca Labs. | 2,056.60 | 26,087.97 | 4,367.43 | 652.46 | 4,185.23 |
| Glaxosmi. Pharma | 1,467.20 | 24,855.84 | 3,224.68 | 110.05 | 2,129.60 |
| Pfizer | 5,330.75 | 24,388.18 | 2,151.65 | 509.13 | 3,534.54 |
| Dr Lal Pathlabs | 2,863.20 | 23,861.91 | 1,273.60 | 223.18 | 1,106.64 |
| Syngene Intl. | 573.90 | 22,956.00 | 2,011.90 | 411.50 | 3,313.70 |
Quick Links for Abbott India:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
